We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Res-Care, Inc. (MM) | NASDAQ:RSCR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.2775 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13E-3
RULE 13e-3 TRANSACTION STATEMENT
Under Section 13(e) of the Securities Exchange Act of 1934
(Amendment No. 3)
RES-CARE, INC.
(Name of the Subject Company)
RES-CARE, INC.
(Name of Person Filing Statement)
Common Stock, no par value
(Title of Class of Securities)
760943100
(CUSIP Number of Class of Securities)
David W. Miles
Res-Care, Inc.
9901 Linn Station Road
Louisville, Kentucky 40223
(502) 394-2100
(Name, address and telephone number of person authorized to receive
notices and communications on behalf of filing person)
With copies to:
Alan K. MacDonald
Frost Brown Todd LLC
400 West Market Street, 32 nd Floor
Louisville, Kentucky 40202
(502) 589-5400
This statement is filed in connection with (check the appropriate box):
a. |
x |
The filing of solicitation materials or an information statement subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the Securities Exchange Act of 1934. |
|
|
|
b. |
o |
The filing of a registration statement under the Securities Act of 1933. |
|
|
|
c. |
o |
A tender offer. |
|
|
|
d. |
o |
None of the above. |
Check the following box if the soliciting materials or information statement referred to in checking box (a) are preliminary copies: o
Check the following box if the filing is a final amendment reporting the results of the transaction: o
CALCULATION OF FILING FEE
Transaction Valuation* |
|
Amount of Filing Fee** |
|
$340,732,402 |
|
$24,294.22 |
|
* |
Estimated for purposes of calculating the filing fee. Calculated by multiplying (i) 25,715,653, which is the difference between 29,415,653, the number of shares of common stock, no par value (Shares), of Res-Care, Inc. (ResCare or, the Company) outstanding as of September 30, 2010, and 3,700,000, which is the number of Shares beneficially owned by Onex Corporation and its affiliates by (ii) $13.25, which is the per Share tender offer price. |
|
|
** |
The filing fee, calculated in accordance with Rule 0-11 of the Securities Exchange Act of 1934, is calculated by multiplying the Transaction Valuation by .0000713. |
|
|
x |
Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
Amount Previously Paid: $24,294.22
Form or Registration No.: Schedule TO-T
Filing Party: Onex Rescare Acquisition, LLC
Date Filed: October 7, 2010
This Amendment No. 3 (this Amendment) amends and supplements the Rule 13e-3 Transaction Statement on Schedule 13E-3 originally filed by ResCare with the Securities and Exchange Commission (the SEC) on October 7, 2010 (as amended from time to time, the Schedule 13E-3 or the Transaction Statement), relating to the cash tender offer by Onex Rescare Acquisition, LLC, a Delaware limited liability company (Purchaser), as disclosed in the Tender Offer Statement and Rule 13e-3 Transaction Statement on Schedule TO that was originally filed by Purchaser with the SEC on October 7, 2010 (as amended or supplemented from time to time, the Schedule TO), to purchase all of the outstanding common shares of ResCare, other than shares owned by Purchaser and its affiliates and certain members of ResCares management who agreed to exchange their shares for equity in Purchaser, at a price of $13.25 per share, net to the seller in cash, without interest and less any required withholding taxes, upon the terms and subject to the conditions set forth in the Amended and Restated Offer to Purchase, dated October 25, 2010 (the Offer to Purchase), and the related Letter of Transmittal, dated October 7, 2010 (which, together with the Offer to Purchase, as each may be amended or supplemented from time to time, constitute the Offer). Pursuant to the tender offer, Purchaser acquired 21,044,765 ResCare common shares.
This Amendment relates to the second and final step in Purchasers acquisition of all of the issued and outstanding ResCare common shares, a statutory share exchange. In the share exchange, each share that was not validly tendered in the tender offer will be converted into the right to receive $13.25 in cash, without interest and less any applicable withholding taxes, other than (a) shares held by shareholders who are entitled to and who properly exercise, and do not withdraw or lose, dissenters rights under Kentucky law, (b) shares owned by Purchaser or any affiliate of Purchaser, and (c) shares held by certain members of ResCares management who have agreed to exchange their ResCare shares for an equity ownership position in Purchaser.
Concurrently with the filing of this Amendment, ResCare is filing with the SEC a definitive Proxy Statement on Schedule 14A (the Proxy Statement). The Proxy Statement relates to a special meeting of ResCares shareholders. At the special meeting, ResCares shareholders will vote upon a proposal to approve the share exchange. As a result of the tender offer, Purchaser and its affiliates own and have the right to vote a sufficient number of ResCares shares to ensure approval of the share exchange at the special meeting without regard to the vote of any other shareholder. The Proxy Statement is included as an exhibit hereto and a copy of the Agreement and Plan of Share Exchange between ResCare and Purchaser is attached as Annex A to the Proxy Statement. The information contained in the Proxy Statement, including all annexes thereto, is expressly incorporated herein by reference, and the responses to each item herein are qualified in their entirety by the information contained in the Proxy Statement and its annexes.
This Amendment is being filed to reflect certain updates as reflected below. Except as specifically noted herein, the information set forth in the Schedule 13E-3 remains unchanged.
The information included in and incorporated by reference into the following Items of the Schedule 13E-3 is hereby amended and supplemented with the following:
Item 1. Summary Term Sheet.
The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:
SUMMARY TERM SHEET
Item 2. Subject Company Information.
(b) Securities . The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
THE SPECIAL MEETINGRecord Date; Shares Entitled to Vote; Quorum
(c)-(d) Trading Market and Price; Dividends . The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
INFORMATION ABOUT RESCAREPrice Range of Shares; Dividends
Item 4. Terms of the Transaction.
(a)(2) Material TermsMergers or Similar Transactions . The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
THE SUMMARY TERM SHEET
THE SPECIAL MEETING
SPECIAL FACTORS
THE SHARE EXCHANGE AGREEMENT
(c) Different Terms . The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
THE SUMMARY TERM SHEET
THE SPECIAL MEETING
SPECIAL FACTORS
THE SHARE EXCHANGE AGREEMENT
(d) Appraisal Rights . The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
THE SUMMARY TERM SHEETOther Important ConsiderationsDissenters Rights
SUMMARY OF PROCEDURE TO EXERCISE SHAREHOLDERS RIGHT TO DISSENT
ANNEX CSubtitle 13 of the Kentucky Business Corporation Act
Item 5. Past Contacts, Transactions, Negotiations and Agreements.
(b)-(c) Significant Corporate Events; Negotiations or Contacts . The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
THE SUMMARY TERM SHEET
THE SPECIAL MEETING
SPECIAL FACTORS
INFORMATION ABOUT RESCARE
Item 11. Interest in Securities of the Subject Company.
(a)-(b) Securities Ownership; Securities Transactions . The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
THE SUMMARY TERM SHEET
THE SPECIAL MEETING
THE PARTIES TO THE SHARE EXCHANGE
SPECIAL FACTORS
INFORMATION ABOUT RESCARE
Item 13. Financial Statements.
(a) Financial Information . The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:
INFORMATION ABOUT RESCARESummary Financial Information
FINANCIAL STATEMENTS
Item 15. Additional Information.
(b) Other Material Information . The information set forth in the Proxy Statement, including all annexes thereto, is incorporated herein by reference.
Item 16. Exhibits.
(a)(1)(x) |
|
Definitive Proxy Statement of Res-Care, Inc. (incorporated by reference to the Schedule 14A filed with the SEC by ResCare on December 3, 2010). |
|
|
|
(a)(5)(ii) |
|
Text of Press Release issued by ResCare, dated November 23, 2010 (incorporated by reference to the Schedule 14A filed with the SEC by ResCare on November 23, 2010). |
1 Year Res-Care, Inc. (MM) Chart |
1 Month Res-Care, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions